The phosphatidylinositol 3-kinase (PI3K) pathway, also known as AKT (protein kinase B/PKB) plays a significant role in tumor cell expansion and survival, and thus has a tremendous effect on how patients respond to immunotherapy [53]. The gene discussed is AKT1; the disease is neoplasm.